Australia Markets closed

Why the Polynovo share price rocketed 27% higher today

James Mickleboro
bull market investing

The Polynovo Ltd (ASX: PNV) share price is ending the week on a very positive note.

In early afternoon trade the medical device company’s shares are the best performers on the ASX 200 with a 17.5% gain to $2.04.

At one stage the Polynovo share price was up as much as 27% to $2.20.

When its shares reached that level, it meant they were up an incredible 266% since the start of the year.

Why is the Polynovo share price rocketing higher today?

Investors have been fighting to get hold of its shares after a positive announcement relating to its NovoSorb BTM product.

The NovoSorb BTM product is a dermal scaffold for the regeneration of the dermis when lost through extensive surgery or burn.

This morning the company announced that it has been granted certificate of conformance (CE Mark) approval for sale throughout the UK/Ireland and the European Union.

It has been approved for use in all full dermal loss procedures. This includes full thickness burns, trauma, reconstructive surgery, and diabetic foot ulcers.

What now?

PolyNovo advised that it will now need to file documents with each European market. However, this is a routine administrative function and will not delay sales and shipments.

PolyNovo CEO, Paul Brennan, said: “This is a watershed moment for PolyNovo. Our global regulatory approvals have expanded significantly with this certification. Our early preparedness in UK/Ireland and DACH should mean a shortened timeline to booking our first sale. We also believe CE approval will fast track regulatory approval in a number of other countries including several in South East Asia”.

This sentiment was echoed by PolyNovo’s chairman, David Williams. He said: “We are confident we will have early sales in the UK/Ireland and in Germany through PMI. We will now quickly expand our direct sales force in other parts of the EU.”

Elsewhere, the Next Science Ltd (ASX: NXS) share price is racing higher today. The medical technology company’s are up 8% after being granted its first acne-related patent.

The post Why the Polynovo share price rocketed 27% higher today appeared first on Motley Fool Australia.

Missed these gains? Then don't miss these highly rated shares that have been named as buys.

NEW. Analyst Names Best Stocks to Buy in 2020….

Our Motley Fool experts have just released a brand new FREE report, detailing 5 dirt cheap shares that you can buy today.

One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

Another is a diversified conglomerate trading near a 52-week low all while offering a 2.8% fully franked yield...

Plus 3 more cheap bets that could position you to profit over the next 12 months!

See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.


More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019